STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core.

The VP8* subunit of rotavirus spike protein VP4 contains a sialic acid (Sia)-binding domain important for host cell attachment and infection. In this study, the binding epitope of the N-acetylneuraminic acid (Neu5Ac) derivatives has been characterized by saturation transfer difference (STD) nuclear magnetic resonance (NMR) spectroscopy. From this STD NMR data, it is proposed that the VP8* core recognizes an identical binding epitope in both methyl alpha-D-N-acetylneuraminide (Neu5Acalpha2Me) and the disaccharide methyl S-(alpha-D-N-acetylneuraminosyl)-(2-->6)-6-thio-beta-D-galactopyranoside (Neu5Ac-alpha(2,6)-S-Galbeta1Me). In the VP8*-disaccharide complex, the Neu5Ac moiety contributes to the majority of interaction with the protein, whereas the galactose moiety is solvent-exposed. Molecular dynamics calculations of the VP8*-disaccharide complex indicated that the galactose moiety is unable to adopt a conformation that is in close proximity to the protein surface. STD NMR experiments with methyl 9-O-acetyl-alpha-D-N-acetylneuraminide (Neu5,9Ac(2)alpha2Me) in complex with rhesus rotavirus (RRV) VP8* revealed that both the N-acetamide and 9-O-acetate moieties are in close proximity to the Sia-binding domain, with the N-acetamide's methyl group being saturated to a larger extent, indicating a closer association with the protein. RRV VP8* does not appear to significantly recognize the unsaturated Neu5Ac derivative [2-deoxy-2,3-didehydro-D-N-acetylneuraminic acid (Neu5Ac2en)]. Molecular modeling of the protein-Neu5Ac2en complex indicates that key interactions between the protein and the unsaturated Neu5Ac derivative when compared with Neu5Acalpha2Me would not be sustained. Neu5Acalpha2Me, Neu5Ac-alpha(2,6)-S-Galbeta1Me, Neu5,9Ac(2)alpha2Me, and Neu5Ac2en inhibited rotavirus infection of MA104 cells by 61%, 35%, 30%, and 0%, respectively, at 10 mM concentration. NMR spectroscopic, molecular modeling, and infectivity inhibition results are in excellent agreement and provide valuable information for the design of inhibitors of rotavirus infection.

[1]  G. Holloway,et al.  Crystallization and preliminary X-ray diffraction analysis of the sialic acid-binding domain (VP8*) of porcine rotavirus strain CRW-8. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[2]  B. M. Pinto,et al.  A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II. , 2005, Biochemistry.

[3]  R. Glass,et al.  Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. , 2004, Vaccine.

[4]  J. Menting,et al.  Saturation transfer difference (STD) 1H‐NMR experiments and in silico docking experiments to probe the binding of N‐acetylneuraminic acid and derivatives to Vibrio cholerae sialidase , 2004, Proteins.

[5]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[6]  A. Svennerholm,et al.  Progress in enteric vaccine development , 2004 .

[7]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[8]  S. Harrison,et al.  Specificity and Affinity of Sialic Acid Binding by the Rhesus Rotavirus VP8* Core , 2002, Journal of Virology.

[9]  E. Méndez,et al.  Molecular biology of rotavirus cell entry. , 2002, Archives of medical research.

[10]  M. Estes,et al.  Initial Interaction of Rotavirus Strains with N-Acetylneuraminic (Sialic) Acid Residues on the Cell Surface Correlates with VP4 Genotype, Not Species of Origin , 2002, Journal of Virology.

[11]  Gerhard Wagner,et al.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site , 2002, The EMBO journal.

[12]  M. Estes,et al.  VLA-2 (α2β1) Integrin Promotes Rotavirus Entry into Cells but Is Not Necessary for Rotavirus Attachment , 2002, Journal of Virology.

[13]  M. Yeager,et al.  Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. , 2001, Journal of molecular biology.

[14]  M. Estes,et al.  Differential Infection of Polarized Epithelial Cell Lines by Sialic Acid-Dependent and Sialic Acid-Independent Rotavirus Strains , 2001, Journal of Virology.

[15]  T. Haselhorst,et al.  Molecular recognition of sialyl Lewis(x) and related saccharides by two lectins. , 2001, Journal of the American Chemical Society.

[16]  S. Harrison,et al.  Proteolysis of Monomeric Recombinant Rotavirus VP4 Yields an Oligomeric VP5* Core , 2001, Journal of Virology.

[17]  B. Meyer,et al.  Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. , 2001, Journal of the American Chemical Society.

[18]  H. Greenberg,et al.  Challenges for rotavirus vaccines. , 2001, Virology.

[19]  N. Roche,et al.  Glycosphingolipid Binding Specificities of Rotavirus: Identification of a Sialic Acid-Binding Epitope , 2001, Journal of Virology.

[20]  Junmei Wang,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000, J. Comput. Chem..

[21]  E. Méndez,et al.  The VP5 Domain of VP4 Can Mediate Attachment of Rotaviruses to Cells , 2000, Journal of Virology.

[22]  Y. Takada,et al.  Integrins α2β1 and α4β1 Can Mediate SA11 Rotavirus Attachment and Entry into Cells , 2000, Journal of Virology.

[23]  E. Méndez,et al.  Entry of rotaviruses is a multistep process. , 1999, Virology.

[24]  M. Kiso,et al.  Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. , 1999, Journal of biochemistry.

[25]  Bernd Meyer,et al.  Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.

[26]  S. Londrigan,et al.  Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Kiefel,et al.  Synthesis and biological evaluation of N-acetylneuraminic acid-based rotavirus inhibitors. , 1996, Journal of medicinal chemistry.

[28]  H. Greenberg,et al.  Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo , 1996, Journal of virology.

[29]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[30]  M. Yeager,et al.  Three‐dimensional structure of the rotavirus haemagglutinin VP4 by cryo‐electron microscopy and difference map analysis. , 1994, The EMBO journal.

[31]  H. Gelberg,et al.  Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition , 1994, Journal of virology.

[32]  W. Chiu,et al.  Three-dimensional visualization of the rotavirus hemagglutinin structure , 1993, Cell.

[33]  K. Fukudome,et al.  Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. , 1989, Virology.

[34]  H. Greenberg,et al.  Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus , 1983, Journal of virology.

[35]  R. Spendlove,et al.  Trypsin enhancement of rotavirus infectivity: mechanism of enhancement , 1981, Journal of virology.

[36]  H. Tuppy,et al.  [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids]. , 1969, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[37]  I. Holmes,et al.  Characterisation of G serotype dependent non-antibody inhibitors of rotavirus in normal mouse serum , 1998, Archives of Virology.

[38]  B. Långström,et al.  Synthesis of Methyl and Allyl alpha-Glycosides of N-Acetylneuraminic Acid in the Absence of Added Promoter. , 1998 .

[39]  R. Yolken,et al.  SA11 rotavirus is specifically inhibited by an acetylated sialic acid. , 1990, The Journal of infectious diseases.

[40]  D. Osguthorpe,et al.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.